Two-pronged Cell Therapy: Engineering T Cells to Redirect Bystander T- and NK-Cells to Pediatric Cancer |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation |
Development of AAV Vectors for Efficient Targeting and Elimination of Osteosarcoma Tumor-Initiating Cells |
University of Florida |
Cure4Cam Childhood Cancer Foundation |
Targeting the Six1/Eya Transcriptional Complex to Inhibit Pediatric Sarcomas |
University of Colorado Denver |
Cure4Cam Childhood Cancer Foundation |
Development of Targeted Leukemia Inhibitors Using Nanoparticle Delivery |
University of Massachusetts Medical School |
I Care I Cure |
Optimizing Engager T-cells for CD19+ Malignancies |
Baylor College of Medicine |
Northwestern Mutual Foundation |
Identification of Resistance Mechanisms and Novel Therapeutic Strategies in Tyrosine Kinase Inhibitor Resistant FLT3/ITD Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center |
Northwestern Mutual Foundation |
Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma |
University of Michigan |
Northwestern Mutual Foundation |
A Developmental Model to Characterize the Epigenetic Origins of the Retinoblastoma Tumor Initiating Cell |
The Johns Hopkins University School of Medicine |
Northwestern Mutual Foundation |
B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers
|
University of Texas Southwestern Medical Center |
Cure4Cam Childhood Cancer Foundation |
Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma
|
Beckman Research Institute of City of Hope |
I Care I Cure |